Unio Capital LLC Eli Lilly & CO Transaction History

Unio Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $735,791 - $867,401	-1,401 Reduced 12.66%	9,668 $5.64 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.99 Million - $2.74 Million	-4,574 Reduced 29.24%	11,069 $5.95 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.5 Million - $2.01 Million	-4,286 Reduced 21.51%	15,643 $7.34 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $110,273 - $129,511	-355 Reduced 1.75%	19,929 $6.84 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $283,285 - $330,084	-881 Reduced 4.16%	20,284 $7.42 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $36,170 - $41,220	-122 Reduced 0.57%	21,165 $6.84 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $5.93 Million - $6.97 Million	21,287 New	21,287 $6.9 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Unio Capital LLC with notifications on news.